SlideShare ist ein Scribd-Unternehmen logo
1 von 39
OBJECTIVES AND POLICIES OF CGMP
INVENTORY MANAGEMENT AND
CONTROL
PRESENTED BY
SWEETY KURIAKOSE
M PHARM 1ST SEMESTER
DEPARTMENT OF PHARMACEUTICS
CONTENTS
 INTRODUCTION
 IMPORTANCE OF CGMP
 OBJECTIVES
 POLICIES OF CGMP
 INVENTORY CONTROL
 OBJECTIVES
 FUNCTIONS
 INVENTORY COST
 ECONOMIC ORDER QUANTITY
 IMPORTANT TERMS RELATED TO THE
INVENTORY CONTROL
 TECHNIQUES OF INVENTORY CONTROL
CURRENT GOOD MANUFACTURING
PRACTICES
 CGMP refers to the regulations given by the USFDA under
the authority of Food Drug and Cosmetic act
 CGMPs provides the system that assure proper design,
monitoring, and control of manufacturing processes and
facilities.
 This assures the identity strength, quality and purity of drug
products by requiring that manufactures of medications
adequately control manufacturing operations.
TITLE 21 of Code of federal regulations (CFR) -
Food Drug and Cosmetic Act
Current good
manufacturing practices
in manufacturing
process is packing and
holding of drug.
21CFR210
• Current GMP for
finished
pharmaceuticals.21CFR211
IMPORTANCE OF CGMP
 It prevents the incidents of product mix up, contamination,
deviations, failures, and errors which assures that the drug
products meet the required quality standards.
 It assures that the drugs are manufactured under good
conditions, equipment is properly maintained and
calibrated, by who are qualified and fully trained and
processes that are reliable and reproducible
OBJECTIVES OF THE CGMP
 Ensure that products are consistently manufactured and
controlled to the specified quality.
 Concerned with all aspects of production and quality
control
 In the manufacture of cosmetic products of specified
quality
 Ensure that the consumer receives products of specified
quality.
 CGMP regulations assures the identity, strength, quality,
and purity of drug products
CURRENT GMP POLICIES
Section 1: PERSONNEL
 There shall be an adequate number of personnel at all levels
having knowledge, skills and capabilities relevant to their
assigned functions, in good mental and physical health to be
able to execute their duties.
 The organizational structure of the company shall be such
that the production and the quality assurance are headed by
different managers like quality control manager, production
control manager etc.
 All employees who are engaged in the manufacturing
activities shall be trained properly that the employees
perform in accordance with the principles of Current Good
Manufacturing
Section 2: PREMISES
 The premises for manufacturing shall be of suitable size,
design, construction and location to facilitate proper
operation, cleaning and maintenance.
 The individual working areas shall be adequate so that
any risk of confusion, cross-contamination will
adversely affect the quality of drugs and devices will be
avoided.
 Production areas shall be ventilated with air control
facilities
 Avoid exposed overhead roof joints, pipes and ducts.
 The condition of buildings shall be reviewed regularly,
and repaired where necessary
Section 3: EQUIPMENT
 Equipment used in the manufacturing of drug products
shall be of appropriate design and construction, adequate
size
 It should be properly installed in order to assure product
quality and process reproducibility and to facilitate its
cleaning and maintenance
 Equipment shall be subjected to regular maintenance
checks at appropriate intervals to prevent malfunctions or
contamination
 Written procedures shall be established and followed for
maintenance of equipment.
 Validation shall be conducted following a Validation
Protocol
Section 4: SANITATION AND HYGIENE
 The sanitation and hygiene program cover personnel,
premises, equipment and apparatus, production materials
and containers and anything that could become a source
of contamination to the product.
 It should be validated and periodically assessed to ensure
that the effectiveness of the operation
 Direct contact shall be avoided between the operator and
raw materials, intermediate or bulk products.
 Records of cleaning, sanitizing, sterilization and
inspection shall be maintained.
Section 5: STORAGE OF STARTING AND PACKAGING
MATERIALS AND FINISHED PRODUCTS
 Materials shall be stored in an order to prevent any risk of
mix-up or contamination and to facilitate inspection and
maintenance
 The materials shall be stored under suitable environmental
condition
 All raw materials, packaging materials, intermediate and
bulk products returned to storage areas shall be properly
documented and reconciled.
 Rejected raw materials and packaging materials shall not
be stored together with approved materials
 The First Expiry First Out system (FEFO) on approved raw
materials shall be used.
Section 6: PRODUCTION
 Production shall follow defined procedures capable to
provide assurance that drug products to conform their
specification
 Manufacturing facilities and methods shall be designed
to prevent cross-contamination.
 Process Validation
 The presence in a drug product of any contaminant is
unacceptable
 A batch and/or lot numbering system applied to a
processing state and finished product
Section 7: PACKAGING
 Packaging operations shall be performed under strict
control to protect the identity, integrity and quality of the
final package.
 All packaging operations shall proceed in accordance
with a SOP.
 Coding of components shall take place in an area
isolated from other packaging operations
 Written in-process control procedures shall be followed.
Section 8: FINISHED PRODUCT QUARANTINE AND
DELIVERY TO WAREHOUSE
 Finished product quarantine is the last point of control
before the product enters the warehouse and available
for distribution to the market.
 Strict controls shall be maintained to ensure that the
product and its packaging records meet all specified
requirements before release to the warehouse.
 Written procedures should be maintained for the transfer
of finished product into the quarantined area, and
subsequent transfer to the finished goods warehouse.
Section 9: QUALITY CONTROL
 Quality Control is an essential part of Good
Manufacturing Practices to provide assurance that the
products will be consistently of a quality appropriate to
their intended use
 An independent quality control unit shall be established.
 A quality control system shall be developed to ensure
that finished products contain the correct materials of
specified quality and quantity and are manufactured
under proper conditions following standard procedures.
 Quality control involves all analytical functions
conducted in the laboratory, including sampling,
inspecting and testing of starting materials, intermediate,
bulk and finished products
Section 10: DOCUMENTATION
 Documents shall be prepared and designed carefully for
easy, correct and effective use.
 Documents shall contain records of activities within
production, quality control, equipment maintenance,
warehouse, distribution and other specific activities
related to Good Manufacturing Practice
 A master production document should include the
product name, dosage form, strength and description,
the writer’s name and department, name of verifier and
list of document distribution.
 Batch Processing Record
 Master packaging procedure
Section 11: SELF INSPECTION
 The purpose of self-inspection is to evaluate the
manufacturer’s compliance with Good Manufacturing
Practices on all aspects of production and quality control.
 Self-inspection shall be performed routinely and corrective
actions shall be implemented.
 A team consisting of personnel who can evaluate the
implementation of Good Manufacturing Practices
objectively shall be appointed.
 The procedure and record for self-inspection shall be
documented
Section 12: GUIDELINES FOR HANDLING OF
PRODUCT COMPLAINT, PRODUCT RECALL AND
OR RETURNED PRODUCT
 A product complaint and report may relate to the
quality, adverse reaction or other therapeutic effect of
the product
 A follow-up action shall be taken after investigation and
evaluation of the product complaint and report
 A product recall is a process of withdrawing one or
more batches or all of a certain product from market
distribution
 A returned product is a finished product which is
already in distribution and returned to the manufacturer
due to complaint, damage, expiration, validity or other
reasons.
INVENTORY MANAGEMENT AND
CONTROL
 Inventory control is the process by which inventory is
measured and regulated according to predetermined norms
such as economic lot size for order or production, safety
stock, minimum level, maximum level, order level etc..
 Inventory means all the raw materials, semi processed
materials, semi processed materials and finished goods
etc.
 Inventory management is essential to maintain a large
size inventory for smooth and efficient production and
also for sales operation
 To minimise the possibility of disruption in the production
schedule for want of raw materials, consumables, spares and
other store items.
 To keep down the capital investment in inventories.
 To ensure adequate stock of finished product to meet the
deliver requirement of the customer.
 To reduce the loss due to changes in prices of inventory
items.
 To facilitate the intermittent production of several products on
the same facility.
 To stabilize employment and improve labour relations by
inventory of human resources and machine efforts.
OBJECTIVES OF INVENTORY
CONTROL
 Minimise the carrying cost of the materials.
 Maintenance of sufficient stock of materials to take care of
the requirement during the period of short supply
 Maintenance of sufficient stock of finished goods for smooth
sales operations.
 Protect the inventory against deterioration, obsolescence and
unauthorized use.
 To keep the inventories as low as possible which leads to
consistent price of market conditions.
 Maintain the proper records and assess the stock position of
the materials.
FUNCTIONS OF INVENTORY
CONTROL
INVENTORY COSTS
ORDERING
COST
• cost of ordering the item
 Expenses from raising the indent, Purchase
requisition by user department till the execution
of order
INVENTORY
CARRYING
COST
• Costs incurred for holding the volume of
inventory
 Obsolescence cost, Deterioration cost, Taxes on
inventory, Capital cost
OUT OF
STOCK COST
• Loss due to non availability of material
• Break down/delay in production, lost sales, loss
of service to custom
ECONOMIC ORDER QUANTIY(EOQ)
 It is the technique of ordering materials whenever stock
reaches the reorder point.
 It deals when the cost of procurement and handling of
inventory are at optimum level and total cost is minimum.
 In this technique, the order quantity is larger than a single
period’s requirement so that ordering cost and holding cost
balance out.
 EOQ=√2DS/H
D- demand
S- cost of placing the order
H- annual holding and storage cost per unit of inventory
Minimum stock level
Maximum Stock Level
Reorder Level
Safety Stock
Lead Time(servicing lead time, Supplier’s lead time)
Reserve Stock
TERMINOLOGIES RELATED TO
INVENTORY CONTROL
TECHNIQUES OF INVENTORY CONTROL
ABC ANALYSIS
Always Better Control
Based on the annual inventory values
PROCEDURE FOR ABC ANALYSIS
List of all materials used in the
company
Work out their annual
consumption value and money
value
Multiply each item’s annual value
by its money value
Arrange the items in the
descending order
find out each item’s percentage of
the total inventory
 It ensures the better control over costly items
 It helps in developing scientific method of controlling
inventories
 It helps in maintaining the stock in a better way
 It helps in reducing the storage cost
 It helps in maintaining enough stocks of group A, B, and
C items
ADVANTAGES OF ABC ANALYSIS
 Inconvenient to compute when items are in large
numbers
 More chance of deterioration of item of class C when
it is purchased in bulk
 Loose control on C items causes shortages
 Focuses on money value and not on functional
importance causing shortage of critical items
 Does not consider variation of prices with time
DISADVANTAGES OF ABC ANALYSIS
VED ANALYSIS
 Based on the utility of the materials.
VITAL
• Ventilator
• Morphine
• Adrenaline
injection
• V belts
• bearings
ESSENTIAL
• Anti malarial
• Sedatives
• Thermometer
• Flow meters
• Stand by
powerset
DESIRABLE
• Cetrizine
• Syringes
• Vitamins
• Analgesics
• Other
equipments
COMBINATION OF ABC AND VED ANALYSIS
CATEGORY V- ITEMS E- ITEMS D- ITEMS
A. ITEMS Constant
control and
regular follow
up, AV
Moderate
stocks, AE
nil stocks, AD
B ITEMS Moderate
stocks, BV
Moderate
stocks, BE
Low stocks,
BD
C ITEMS High stocks,
CV
Moderate
stocks, CE
Very low
stocks, CD
FSN ANAYSIS
 Based on the quantity, the rate of consumption, pattern of
issues from stores
FAST
MOVING
SLOW
MOVING
NON-
MOVING
• Crocin
• Digene
• Becosules
• Cifran
• Brufen
• Actilase injection
• Terlipressin
HML ANALYSIS
 Based on their unit cost
HIGH VALUE
MEDIUM VALUE
LOW VALUE
XYZ ANALYSIS
 Based on the value of inventory of materials
X
• High stock value
• X ray film, blood bag
Y
• Medium stock value
• ECG recording paper, fistula needle
Z
• Low stock value
• ECG jelly, syringes
GOLF ANALYSIS
 Based on the availability and nature of
suppliers
GOLF
govern
ment
ordinary
local
foreign
SDE ANALYSIS
 Based on their availability of the item or the length of its
lead time
DIFFICULT
SOS ANALYSIS
 Based on the seasonality of items
SEASONAL
OFF- SEASONAL
REFERENCE
 www.fda .gov.in
 How to practice GMPs by P.P Sharma, pageno.105-284
 Current Good Manufacturing Practice Guidelines for
drugs available at https: www.wipo.int>laws
 Inventory control and management by C. D. J waters.
 Methods of inventory control available at http://www.
Yourarticlelibrary.com
 Tom Jose V, Akhilesh Jayakumar, et.al , analysis of
inventory control techniques, International Journal Of
Scientific And Research Publications, Volume 3
Objectives and policies of cGMP & Inventory management and control

Weitere ähnliche Inhalte

Was ist angesagt?

Cmc, post approval and regulation
Cmc, post approval and regulationCmc, post approval and regulation
Cmc, post approval and regulationHimal Barakoti
 
Validation and calibration of master plan
Validation and calibration of master planValidation and calibration of master plan
Validation and calibration of master planPrinka Choudhary
 
Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)Himal Barakoti
 
ICH & WHO GUIDELINES ON validation
ICH & WHO GUIDELINES ON validationICH & WHO GUIDELINES ON validation
ICH & WHO GUIDELINES ON validationSACHIN C P
 
API, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptxAPI, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptxPawanDhamala1
 
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESREGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESArunpandiyan59
 
Large & Small Volume Parenteral
Large & Small Volume ParenteralLarge & Small Volume Parenteral
Large & Small Volume ParenteralSreePrakashPandey
 
Single shot vaccines Naveen Balaji
Single shot vaccines Naveen BalajiSingle shot vaccines Naveen Balaji
Single shot vaccines Naveen BalajiNaveen Balaji
 
Consolidation, effect of friction, distribution of forces, compaction profile
Consolidation, effect of friction, distribution of forces, compaction profileConsolidation, effect of friction, distribution of forces, compaction profile
Consolidation, effect of friction, distribution of forces, compaction profileZahid1392
 
Theories of dispersion
Theories of dispersionTheories of dispersion
Theories of dispersionRahul Krishnan
 
Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRODhanshreeBhattad
 
Objectives , policies and principles of cGMP guidelines in pharmaceutical ind...
Objectives , policies and principles of cGMP guidelines in pharmaceutical ind...Objectives , policies and principles of cGMP guidelines in pharmaceutical ind...
Objectives , policies and principles of cGMP guidelines in pharmaceutical ind...JaskiranKaur72
 
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGARegulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGAHimal Barakoti
 
C gmp indutrial and personal relationship trii
C gmp indutrial and personal relationship triiC gmp indutrial and personal relationship trii
C gmp indutrial and personal relationship triiTrilok Shahare
 
Us registration for foreign drugs
Us registration for foreign drugsUs registration for foreign drugs
Us registration for foreign drugsNiva Rani Gogoi
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compactionMehak AggarwAl
 
validation of dosage forms
validation of dosage formsvalidation of dosage forms
validation of dosage formsTejaswi Reddy
 
Validation and calibration master plan
Validation and calibration master planValidation and calibration master plan
Validation and calibration master planBharatlal Sain
 

Was ist angesagt? (20)

Cmc, post approval and regulation
Cmc, post approval and regulationCmc, post approval and regulation
Cmc, post approval and regulation
 
Validation and calibration of master plan
Validation and calibration of master planValidation and calibration of master plan
Validation and calibration of master plan
 
Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)Self micro-emulsifying drug delivery system (SMEDDS)
Self micro-emulsifying drug delivery system (SMEDDS)
 
ICH & WHO GUIDELINES ON validation
ICH & WHO GUIDELINES ON validationICH & WHO GUIDELINES ON validation
ICH & WHO GUIDELINES ON validation
 
API, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptxAPI, BIOLOGICS,NOVEL,THERAPIES........pptx
API, BIOLOGICS,NOVEL,THERAPIES........pptx
 
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESREGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
 
Large & Small Volume Parenteral
Large & Small Volume ParenteralLarge & Small Volume Parenteral
Large & Small Volume Parenteral
 
Single shot vaccines Naveen Balaji
Single shot vaccines Naveen BalajiSingle shot vaccines Naveen Balaji
Single shot vaccines Naveen Balaji
 
Consolidation, effect of friction, distribution of forces, compaction profile
Consolidation, effect of friction, distribution of forces, compaction profileConsolidation, effect of friction, distribution of forces, compaction profile
Consolidation, effect of friction, distribution of forces, compaction profile
 
Theories of dispersion
Theories of dispersionTheories of dispersion
Theories of dispersion
 
Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRO
 
Physics of tablet compression
Physics of tablet compressionPhysics of tablet compression
Physics of tablet compression
 
Objectives , policies and principles of cGMP guidelines in pharmaceutical ind...
Objectives , policies and principles of cGMP guidelines in pharmaceutical ind...Objectives , policies and principles of cGMP guidelines in pharmaceutical ind...
Objectives , policies and principles of cGMP guidelines in pharmaceutical ind...
 
Regulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGARegulatory requirement of EU, MHRA and TGA
Regulatory requirement of EU, MHRA and TGA
 
C gmp indutrial and personal relationship trii
C gmp indutrial and personal relationship triiC gmp indutrial and personal relationship trii
C gmp indutrial and personal relationship trii
 
Us registration for foreign drugs
Us registration for foreign drugsUs registration for foreign drugs
Us registration for foreign drugs
 
Impd dossier
Impd dossierImpd dossier
Impd dossier
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compaction
 
validation of dosage forms
validation of dosage formsvalidation of dosage forms
validation of dosage forms
 
Validation and calibration master plan
Validation and calibration master planValidation and calibration master plan
Validation and calibration master plan
 

Ähnlich wie Objectives and policies of cGMP & Inventory management and control

Ähnlich wie Objectives and policies of cGMP & Inventory management and control (20)

OBJECTIVE AND POLICIES OF CGMP.pptx
OBJECTIVE AND POLICIES OF CGMP.pptxOBJECTIVE AND POLICIES OF CGMP.pptx
OBJECTIVE AND POLICIES OF CGMP.pptx
 
GMP.pptx
GMP.pptxGMP.pptx
GMP.pptx
 
GMP, cGMP, USFDA etc
GMP, cGMP, USFDA etcGMP, cGMP, USFDA etc
GMP, cGMP, USFDA etc
 
To compare GMP requirement of India, US and Europe for tablets.
To compare GMP requirement of India, US and Europe for tablets.To compare GMP requirement of India, US and Europe for tablets.
To compare GMP requirement of India, US and Europe for tablets.
 
National gmp 2072
National gmp 2072National gmp 2072
National gmp 2072
 
cGMP.pptx
cGMP.pptxcGMP.pptx
cGMP.pptx
 
GMP
GMP GMP
GMP
 
GMP Requirements & Drug & Cosmetic Act Provision.pptx
GMP Requirements & Drug & Cosmetic Act Provision.pptxGMP Requirements & Drug & Cosmetic Act Provision.pptx
GMP Requirements & Drug & Cosmetic Act Provision.pptx
 
GMP presentation.pptx
GMP presentation.pptxGMP presentation.pptx
GMP presentation.pptx
 
current good manufacturing practise (cgmp)
current good manufacturing practise (cgmp)current good manufacturing practise (cgmp)
current good manufacturing practise (cgmp)
 
C gmp and industrial management
C gmp and industrial managementC gmp and industrial management
C gmp and industrial management
 
Quality control measures in pharmaceutical industry
Quality control measures in pharmaceutical industryQuality control measures in pharmaceutical industry
Quality control measures in pharmaceutical industry
 
Schedule M-Jurisprudence
Schedule M-JurisprudenceSchedule M-Jurisprudence
Schedule M-Jurisprudence
 
cGMP
cGMPcGMP
cGMP
 
Current good manufacturing practice .pptx
Current good manufacturing practice .pptxCurrent good manufacturing practice .pptx
Current good manufacturing practice .pptx
 
Rajni ppt
Rajni pptRajni ppt
Rajni ppt
 
CGMP.pptx
CGMP.pptxCGMP.pptx
CGMP.pptx
 
Industrial management
Industrial managementIndustrial management
Industrial management
 
GOOD MANUFACTURING.
GOOD MANUFACTURING.GOOD MANUFACTURING.
GOOD MANUFACTURING.
 
Gmp presentation
Gmp presentationGmp presentation
Gmp presentation
 

Mehr von Arul Packiadhas

CONCEPT & TYPE OF VALIDATION OF GOVERNMENT REGULATION
CONCEPT & TYPE OF VALIDATION OF GOVERNMENT REGULATIONCONCEPT & TYPE OF VALIDATION OF GOVERNMENT REGULATION
CONCEPT & TYPE OF VALIDATION OF GOVERNMENT REGULATIONArul Packiadhas
 
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN Arul Packiadhas
 
Regulatory aspects for registration of API in formulation
Regulatory aspects for registration of API  in formulationRegulatory aspects for registration of API  in formulation
Regulatory aspects for registration of API in formulationArul Packiadhas
 
TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL  DRUG  DELIVERY  SYSTEMTRANSDERMAL  DRUG  DELIVERY  SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMArul Packiadhas
 
3D PRINTING IN PHARMACEUTICALS
3D PRINTING  IN PHARMACEUTICALS3D PRINTING  IN PHARMACEUTICALS
3D PRINTING IN PHARMACEUTICALSArul Packiadhas
 

Mehr von Arul Packiadhas (6)

CONCEPT & TYPE OF VALIDATION OF GOVERNMENT REGULATION
CONCEPT & TYPE OF VALIDATION OF GOVERNMENT REGULATIONCONCEPT & TYPE OF VALIDATION OF GOVERNMENT REGULATION
CONCEPT & TYPE OF VALIDATION OF GOVERNMENT REGULATION
 
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
 
Regulatory aspects for registration of API in formulation
Regulatory aspects for registration of API  in formulationRegulatory aspects for registration of API  in formulation
Regulatory aspects for registration of API in formulation
 
TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL  DRUG  DELIVERY  SYSTEMTRANSDERMAL  DRUG  DELIVERY  SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEM
 
Alzet osmotic pumps
Alzet osmotic pumpsAlzet osmotic pumps
Alzet osmotic pumps
 
3D PRINTING IN PHARMACEUTICALS
3D PRINTING  IN PHARMACEUTICALS3D PRINTING  IN PHARMACEUTICALS
3D PRINTING IN PHARMACEUTICALS
 

Kürzlich hochgeladen

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 

Kürzlich hochgeladen (20)

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 

Objectives and policies of cGMP & Inventory management and control

  • 1. OBJECTIVES AND POLICIES OF CGMP INVENTORY MANAGEMENT AND CONTROL PRESENTED BY SWEETY KURIAKOSE M PHARM 1ST SEMESTER DEPARTMENT OF PHARMACEUTICS
  • 2. CONTENTS  INTRODUCTION  IMPORTANCE OF CGMP  OBJECTIVES  POLICIES OF CGMP  INVENTORY CONTROL  OBJECTIVES  FUNCTIONS  INVENTORY COST  ECONOMIC ORDER QUANTITY  IMPORTANT TERMS RELATED TO THE INVENTORY CONTROL  TECHNIQUES OF INVENTORY CONTROL
  • 3. CURRENT GOOD MANUFACTURING PRACTICES  CGMP refers to the regulations given by the USFDA under the authority of Food Drug and Cosmetic act  CGMPs provides the system that assure proper design, monitoring, and control of manufacturing processes and facilities.  This assures the identity strength, quality and purity of drug products by requiring that manufactures of medications adequately control manufacturing operations.
  • 4. TITLE 21 of Code of federal regulations (CFR) - Food Drug and Cosmetic Act Current good manufacturing practices in manufacturing process is packing and holding of drug. 21CFR210 • Current GMP for finished pharmaceuticals.21CFR211
  • 5. IMPORTANCE OF CGMP  It prevents the incidents of product mix up, contamination, deviations, failures, and errors which assures that the drug products meet the required quality standards.  It assures that the drugs are manufactured under good conditions, equipment is properly maintained and calibrated, by who are qualified and fully trained and processes that are reliable and reproducible
  • 6. OBJECTIVES OF THE CGMP  Ensure that products are consistently manufactured and controlled to the specified quality.  Concerned with all aspects of production and quality control  In the manufacture of cosmetic products of specified quality  Ensure that the consumer receives products of specified quality.  CGMP regulations assures the identity, strength, quality, and purity of drug products
  • 7. CURRENT GMP POLICIES Section 1: PERSONNEL  There shall be an adequate number of personnel at all levels having knowledge, skills and capabilities relevant to their assigned functions, in good mental and physical health to be able to execute their duties.  The organizational structure of the company shall be such that the production and the quality assurance are headed by different managers like quality control manager, production control manager etc.  All employees who are engaged in the manufacturing activities shall be trained properly that the employees perform in accordance with the principles of Current Good Manufacturing
  • 8. Section 2: PREMISES  The premises for manufacturing shall be of suitable size, design, construction and location to facilitate proper operation, cleaning and maintenance.  The individual working areas shall be adequate so that any risk of confusion, cross-contamination will adversely affect the quality of drugs and devices will be avoided.  Production areas shall be ventilated with air control facilities  Avoid exposed overhead roof joints, pipes and ducts.  The condition of buildings shall be reviewed regularly, and repaired where necessary
  • 9. Section 3: EQUIPMENT  Equipment used in the manufacturing of drug products shall be of appropriate design and construction, adequate size  It should be properly installed in order to assure product quality and process reproducibility and to facilitate its cleaning and maintenance  Equipment shall be subjected to regular maintenance checks at appropriate intervals to prevent malfunctions or contamination  Written procedures shall be established and followed for maintenance of equipment.  Validation shall be conducted following a Validation Protocol
  • 10. Section 4: SANITATION AND HYGIENE  The sanitation and hygiene program cover personnel, premises, equipment and apparatus, production materials and containers and anything that could become a source of contamination to the product.  It should be validated and periodically assessed to ensure that the effectiveness of the operation  Direct contact shall be avoided between the operator and raw materials, intermediate or bulk products.  Records of cleaning, sanitizing, sterilization and inspection shall be maintained.
  • 11. Section 5: STORAGE OF STARTING AND PACKAGING MATERIALS AND FINISHED PRODUCTS  Materials shall be stored in an order to prevent any risk of mix-up or contamination and to facilitate inspection and maintenance  The materials shall be stored under suitable environmental condition  All raw materials, packaging materials, intermediate and bulk products returned to storage areas shall be properly documented and reconciled.  Rejected raw materials and packaging materials shall not be stored together with approved materials  The First Expiry First Out system (FEFO) on approved raw materials shall be used.
  • 12. Section 6: PRODUCTION  Production shall follow defined procedures capable to provide assurance that drug products to conform their specification  Manufacturing facilities and methods shall be designed to prevent cross-contamination.  Process Validation  The presence in a drug product of any contaminant is unacceptable  A batch and/or lot numbering system applied to a processing state and finished product
  • 13. Section 7: PACKAGING  Packaging operations shall be performed under strict control to protect the identity, integrity and quality of the final package.  All packaging operations shall proceed in accordance with a SOP.  Coding of components shall take place in an area isolated from other packaging operations  Written in-process control procedures shall be followed.
  • 14. Section 8: FINISHED PRODUCT QUARANTINE AND DELIVERY TO WAREHOUSE  Finished product quarantine is the last point of control before the product enters the warehouse and available for distribution to the market.  Strict controls shall be maintained to ensure that the product and its packaging records meet all specified requirements before release to the warehouse.  Written procedures should be maintained for the transfer of finished product into the quarantined area, and subsequent transfer to the finished goods warehouse.
  • 15. Section 9: QUALITY CONTROL  Quality Control is an essential part of Good Manufacturing Practices to provide assurance that the products will be consistently of a quality appropriate to their intended use  An independent quality control unit shall be established.  A quality control system shall be developed to ensure that finished products contain the correct materials of specified quality and quantity and are manufactured under proper conditions following standard procedures.  Quality control involves all analytical functions conducted in the laboratory, including sampling, inspecting and testing of starting materials, intermediate, bulk and finished products
  • 16. Section 10: DOCUMENTATION  Documents shall be prepared and designed carefully for easy, correct and effective use.  Documents shall contain records of activities within production, quality control, equipment maintenance, warehouse, distribution and other specific activities related to Good Manufacturing Practice  A master production document should include the product name, dosage form, strength and description, the writer’s name and department, name of verifier and list of document distribution.  Batch Processing Record  Master packaging procedure
  • 17. Section 11: SELF INSPECTION  The purpose of self-inspection is to evaluate the manufacturer’s compliance with Good Manufacturing Practices on all aspects of production and quality control.  Self-inspection shall be performed routinely and corrective actions shall be implemented.  A team consisting of personnel who can evaluate the implementation of Good Manufacturing Practices objectively shall be appointed.  The procedure and record for self-inspection shall be documented
  • 18. Section 12: GUIDELINES FOR HANDLING OF PRODUCT COMPLAINT, PRODUCT RECALL AND OR RETURNED PRODUCT  A product complaint and report may relate to the quality, adverse reaction or other therapeutic effect of the product  A follow-up action shall be taken after investigation and evaluation of the product complaint and report  A product recall is a process of withdrawing one or more batches or all of a certain product from market distribution  A returned product is a finished product which is already in distribution and returned to the manufacturer due to complaint, damage, expiration, validity or other reasons.
  • 19. INVENTORY MANAGEMENT AND CONTROL  Inventory control is the process by which inventory is measured and regulated according to predetermined norms such as economic lot size for order or production, safety stock, minimum level, maximum level, order level etc..  Inventory means all the raw materials, semi processed materials, semi processed materials and finished goods etc.  Inventory management is essential to maintain a large size inventory for smooth and efficient production and also for sales operation
  • 20.  To minimise the possibility of disruption in the production schedule for want of raw materials, consumables, spares and other store items.  To keep down the capital investment in inventories.  To ensure adequate stock of finished product to meet the deliver requirement of the customer.  To reduce the loss due to changes in prices of inventory items.  To facilitate the intermittent production of several products on the same facility.  To stabilize employment and improve labour relations by inventory of human resources and machine efforts. OBJECTIVES OF INVENTORY CONTROL
  • 21.  Minimise the carrying cost of the materials.  Maintenance of sufficient stock of materials to take care of the requirement during the period of short supply  Maintenance of sufficient stock of finished goods for smooth sales operations.  Protect the inventory against deterioration, obsolescence and unauthorized use.  To keep the inventories as low as possible which leads to consistent price of market conditions.  Maintain the proper records and assess the stock position of the materials. FUNCTIONS OF INVENTORY CONTROL
  • 22. INVENTORY COSTS ORDERING COST • cost of ordering the item  Expenses from raising the indent, Purchase requisition by user department till the execution of order INVENTORY CARRYING COST • Costs incurred for holding the volume of inventory  Obsolescence cost, Deterioration cost, Taxes on inventory, Capital cost OUT OF STOCK COST • Loss due to non availability of material • Break down/delay in production, lost sales, loss of service to custom
  • 23. ECONOMIC ORDER QUANTIY(EOQ)  It is the technique of ordering materials whenever stock reaches the reorder point.  It deals when the cost of procurement and handling of inventory are at optimum level and total cost is minimum.  In this technique, the order quantity is larger than a single period’s requirement so that ordering cost and holding cost balance out.  EOQ=√2DS/H D- demand S- cost of placing the order H- annual holding and storage cost per unit of inventory
  • 24. Minimum stock level Maximum Stock Level Reorder Level Safety Stock Lead Time(servicing lead time, Supplier’s lead time) Reserve Stock TERMINOLOGIES RELATED TO INVENTORY CONTROL
  • 26. ABC ANALYSIS Always Better Control Based on the annual inventory values
  • 27. PROCEDURE FOR ABC ANALYSIS List of all materials used in the company Work out their annual consumption value and money value Multiply each item’s annual value by its money value Arrange the items in the descending order find out each item’s percentage of the total inventory
  • 28.  It ensures the better control over costly items  It helps in developing scientific method of controlling inventories  It helps in maintaining the stock in a better way  It helps in reducing the storage cost  It helps in maintaining enough stocks of group A, B, and C items ADVANTAGES OF ABC ANALYSIS
  • 29.  Inconvenient to compute when items are in large numbers  More chance of deterioration of item of class C when it is purchased in bulk  Loose control on C items causes shortages  Focuses on money value and not on functional importance causing shortage of critical items  Does not consider variation of prices with time DISADVANTAGES OF ABC ANALYSIS
  • 30. VED ANALYSIS  Based on the utility of the materials. VITAL • Ventilator • Morphine • Adrenaline injection • V belts • bearings ESSENTIAL • Anti malarial • Sedatives • Thermometer • Flow meters • Stand by powerset DESIRABLE • Cetrizine • Syringes • Vitamins • Analgesics • Other equipments
  • 31. COMBINATION OF ABC AND VED ANALYSIS CATEGORY V- ITEMS E- ITEMS D- ITEMS A. ITEMS Constant control and regular follow up, AV Moderate stocks, AE nil stocks, AD B ITEMS Moderate stocks, BV Moderate stocks, BE Low stocks, BD C ITEMS High stocks, CV Moderate stocks, CE Very low stocks, CD
  • 32. FSN ANAYSIS  Based on the quantity, the rate of consumption, pattern of issues from stores FAST MOVING SLOW MOVING NON- MOVING • Crocin • Digene • Becosules • Cifran • Brufen • Actilase injection • Terlipressin
  • 33. HML ANALYSIS  Based on their unit cost HIGH VALUE MEDIUM VALUE LOW VALUE
  • 34. XYZ ANALYSIS  Based on the value of inventory of materials X • High stock value • X ray film, blood bag Y • Medium stock value • ECG recording paper, fistula needle Z • Low stock value • ECG jelly, syringes
  • 35. GOLF ANALYSIS  Based on the availability and nature of suppliers GOLF govern ment ordinary local foreign
  • 36. SDE ANALYSIS  Based on their availability of the item or the length of its lead time DIFFICULT
  • 37. SOS ANALYSIS  Based on the seasonality of items SEASONAL OFF- SEASONAL
  • 38. REFERENCE  www.fda .gov.in  How to practice GMPs by P.P Sharma, pageno.105-284  Current Good Manufacturing Practice Guidelines for drugs available at https: www.wipo.int>laws  Inventory control and management by C. D. J waters.  Methods of inventory control available at http://www. Yourarticlelibrary.com  Tom Jose V, Akhilesh Jayakumar, et.al , analysis of inventory control techniques, International Journal Of Scientific And Research Publications, Volume 3

Hinweis der Redaktion

  1. strong quality managements, obtaining appropriate quality raw materials, detecting and investigating product quality deviations and maintaining the reliable testing laboratories.
  2. registered qualified pharmacist or any other related profession, experience, duties and responsibilities of all employees shall be clearly defined,
  3. . Doors that lead from production areas directly to the outside, e.g. fire exits, shall be secured against contamination
  4. Avoids the cross contamination, alter the strength, safety, identity, quality, or purity of the product , sops
  5. apparent illness or open lesions that may adversely affect the quality of products shall not be allowed to handle raw materials, packaging materials.separate clothing
  6. checked for proper identity, condition of container and approval of quality . Proper records
  7. packaging materials, intermediate products and bulk products which are approved by quality control can be dispensed.
  8. Total annual cost=annual purchase cost+ annual holding cost+ annual ordering cost
  9. The stock level at which an order should be placed. . Over stocking of goods . time interval between the placing the order for the materials are actually received in the stores, : Excess usage requirement during normal lead time
  10. cover 10% of the total inventories and consumes about 70% of total budge trequire strict monitoring and maximum follow up, safety stocks or low safety stocks
  11. in controlling and maintain the stock of various spare parts or raw materials
  12. the issues of items in past two or three years are considered. The last date of receipt of the items or the last date of the issue of items whichever is later is considered. helps to avoid investments in non-moving or slow-moving items. helpful in facilitating timely control.
  13. Similar to abc analysis instead of consumption, listed in the descending order of unit value and is up to the management fix the limits for 3 categories.
  14. Study taken up once ina year during annual stock taking, calculated by dividing an item’s current stock value by the total stock value, helps in identifying the items which are extensively stocked10% number of items are stored, accounting for 70% of the total inventory value
  15. The nature of the suppliers will determine the quantity and continuity of supply, lead time payment terms and clerical processing cost and time
  16. to buy seasonal items at low prices and keep inventory or buy at high price during off season.